Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1001667-23-7
2. Sovaprevir [usan]
3. Ach-0141625
4. 2nd9v3mn6o
5. Ach-1625
6. Sovaprevir (usan)
7. 2-pyrrolidinecarboxamide, N-[(1r,2s)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2s,4r)-
8. Sovaprevir [usan:inn]
9. Unii-2nd9v3mn6o
10. Sovaprevir [inn]
11. Prodrug Of Ach-1095
12. Sovaprevir [who-dd]
13. Schembl1462843
14. Chembl2105750
15. Dtxsid00142994
16. Chebi:177769
17. Db12069
18. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
19. D10166
20. Q16892599
21. (2s,4r)-1-((2s)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-((cyclopropanesulfonyl)carbamoyl)-2-ethenylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide
22. (2s,4r)-1-((s)-2-(tert-butyl)-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((7-methoxy-2-phenylquinolin-4-yl)oxy)pyrrolidine-2-carboxamide
23. (2s,4r)-1-((s)-2-tert-butyl-4-oxo-4-(piperidin-1-yl)butanoyl)-n-((1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-vinylcyclopropyl)-4-(7-methoxy-2-phenylquinolin-4-yloxy)pyrrolidine-2-carboxamide
24. (2s,4r)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-ethenylcyclopropyl)-1-((2s)- 3,3-dimethyl-2-(2-oxo-2-(piperidin-1-yl)ethyl)butanoyl)-4-((7-methoxy-2-phenylquinolin- 4-yl)oxy)pyrrolidine-2-carboxamide
25. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulfonylcarbamoyl)-2-vinyl-cyclopropyl]-1-[(2s)-3,3-dimethyl-2-[2-oxo-2-(1-piperidyl)ethyl]butanoyl]-4-[(7-methoxy-2-phenyl-4-quinolyl)oxy]pyrrolidine-2-carboxamide
26. (2s,4r)-n-[(1r,2s)-1-(cyclopropylsulonylcarbamoyl)-2-ethenylcyclopropyl]-1-[(2s)-3,3-dimethyl-2-(2-oxo-2-piperidin-1-ylethyl)butanoyl]-4-(7-methoxy-2-phenylquinolin-4-yl)oxypyrrolidine-2-carboxamide
27. 2-pyrrolidinecarboxamide, N-((1r,2s)-1-(((cyclopropylsulfonyl)amino)carbonyl)-2- Ethenylcyclopropyl)-1-((2s)-3,3-dimethyl-1-oxo-2-(2-oxo-2-(1-piperidinyl)ethyl)butyl)-4-
| Molecular Weight | 800.0 g/mol |
|---|---|
| Molecular Formula | C43H53N5O8S |
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 14 |
| Exact Mass | 799.36148484 g/mol |
| Monoisotopic Mass | 799.36148484 g/mol |
| Topological Polar Surface Area | 173 Ų |
| Heavy Atom Count | 57 |
| Formal Charge | 0 |
| Complexity | 1610 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
52
PharmaCompass offers a list of Sovaprevir API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sovaprevir manufacturer or Sovaprevir supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sovaprevir manufacturer or Sovaprevir supplier.
PharmaCompass also assists you with knowing the Sovaprevir API Price utilized in the formulation of products. Sovaprevir API Price is not always fixed or binding as the Sovaprevir Price is obtained through a variety of data sources. The Sovaprevir Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sovaprevir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sovaprevir, including repackagers and relabelers. The FDA regulates Sovaprevir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sovaprevir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sovaprevir supplier is an individual or a company that provides Sovaprevir active pharmaceutical ingredient (API) or Sovaprevir finished formulations upon request. The Sovaprevir suppliers may include Sovaprevir API manufacturers, exporters, distributors and traders.
Sovaprevir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sovaprevir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sovaprevir GMP manufacturer or Sovaprevir GMP API supplier for your needs.
A Sovaprevir CoA (Certificate of Analysis) is a formal document that attests to Sovaprevir's compliance with Sovaprevir specifications and serves as a tool for batch-level quality control.
Sovaprevir CoA mostly includes findings from lab analyses of a specific batch. For each Sovaprevir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sovaprevir may be tested according to a variety of international standards, such as European Pharmacopoeia (Sovaprevir EP), Sovaprevir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sovaprevir USP).
